Carzo, Fortunato C.
HRN: 15-43-19 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2023
LEVOFLOXACIN 500MG (TAB)
01/14/2023
01/20/2023
ORAL
500mg
OD
Complicated UTI Prob Sec To Nephrolithiasis
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes